drugset / Trial / NCT04780347
Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
Timeline
- Start
- 2020-12-15
- Primary completion
- 2022-12-30
- Completion
- 2023-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 260 mg/m2 | Intravenous |
| Comparator | Capecitabine | Small molecule | 1000 mg/m2 | Oral |